Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

ELIXA Investigators

Research output: Contribution to journalArticlepeer-review

80 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo'. Together they form a unique fingerprint.

Medicine & Life Sciences